🔎 Trials Near Me

Hjem › Skizofreni › Illinois › Chicago

Skizofreni kliniske forsøg i Chicago, IL

21 studier for Skizofreni søger deltagere på steder i og omkring Chicago (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.

Officiel studietekst (engelsk)

Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →

Cognitive Neurocomputational Task Reliability & Clinical Applications Consortium (CNTRACS): Study 1

RekruttererFrivillige med god helbredstilstand velkomne
  • The University of Chicago, Chicago
Alder 18 til 59 · Alle køn · Opdateret 2. okt. 2026 · NCT07853807

A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia

RekruttererFase 1
  • Uptown Research Institute, Chicago
Alder 18 til 55 · Alle køn · Opdateret 28. sep. 2026 · NCT07615426

Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia

RekruttererFase 3
  • Local Institution - 0067, Chicago
  • Pillar Clinical Research -Chicago, Chicago
Alder 18 til 65 · Alle køn · Opdateret 28. sep. 2026 · NCT07686263

NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia

RekruttererFase 3
  • Neurocrine Clinical Site, Chicago
Alder 18 til 65 · Alle køn · Opdateret 25. sep. 2026 · NCT07114874

A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents

RekruttererFase 3
  • Local Institution - 0175, Chicago
  • EmVenio Research Center - Prime Healthcare, Chicago
Alder 5 til 17 · Alle køn · Opdateret 22. sep. 2026 · NCT07424404

A Study of Brenipatide in Adult Participants With Schizophrenia

RekruttererFase 2
  • Re:Cognition Health - Chicago, Chicago
Alder 18 til 55 · Alle køn · Opdateret 22. sep. 2026 · NCT07410507

52-week Open Label Safety-Tolerability Study

RekruttererFase 3
  • Pillar Clinical Research, Chicago
Alder 18 til 65 · Alle køn · Opdateret 9. sep. 2026 · NCT07369154

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)

RekruttererFase 3
  • Local Institution - 0122, Chicago
  • EmVenio Research Center - Prime Healthcare, Chicago
Alder 13 til 17 · Alle køn · Opdateret 4. sep. 2026 · NCT07288567

A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT

RekruttererFase 1
  • Uptown Research Institute, Chicago
Alder 18 til 55 · Alle køn · Opdateret 2. sep. 2026 · NCT07061288

A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia

RekruttererFase 2
  • Clinical Site, Chicago
Alder 18 til 65 · Alle køn · Opdateret 1. sep. 2026 · NCT07459647

Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder

RekruttererFase 3
  • Alkermes Investigator Site, Chicago
Alder 10 til 17 · Alle køn · Opdateret 14. aug. 2026 · NCT05303064

Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia

RekruttererFase 2
  • Uptown Research Institute LLC, Chicago
  • Pillar Clinical Research LLC, Chicago
Alder 18 til 65 · Alle køn · Opdateret 29. jul. 2026 · NCT07467993

Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia

RekruttererFase 3
  • Pillar Clinical Research, Chicago
Alder 18 til 65 · Alle køn · Opdateret 27. jul. 2026 · NCT07363577

A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia

RekruttererFase 2
  • Uptown Research Institute, Chicago
Alder 18 til 55 · Alle køn · Opdateret 23. jun. 2026 · NCT07191483

A Study to Evaluate the Effect of KarXT on Urological Safety

RekruttererFase 4
  • Uptown Research Institute, Chicago
  • Pillar Clinical Research -Chicago, Chicago
Alder 18 til 65 · Alle køn · Opdateret 3. jun. 2026 · NCT07221877

CLOZAPINE Response in Biotype-1

RekruttererFase 4
  • University of Chicago, Chicago
Alder 18 til 60 · Alle køn · Opdateret 11. maj 2026 · NCT04580134

Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services

RekruttererObservationsstudie
  • University of Chicago Medical Center, Chicago
Alder 18 til 40 · Alle køn · Opdateret 10. mar. 2026 · NCT06740383

NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

RekruttererFase 3
  • Neurocrine Clinical Site, Chicago
Alder 18 til 65 · Alle køn · Opdateret 6. mar. 2026 · NCT06963034

Randomized Withdrawal Study in Patients With Schizophrenia

RekruttererFase 3
  • Vanda Investigational Site, Chicago
Alder 18 til 65 · Alle køn · Opdateret 12. jan. 2026 · NCT06961968

Study of ALTO-101 in Patients With Schizophrenia

RekruttererFase 2
  • Site 5056, Chicago
Alder 21 til 55 · Alle køn · Opdateret 26. dec. 2025 · NCT06502964

Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia

RekruttererFase 3Frivillige med god helbredstilstand velkomne
  • Reviva site, Chicago
Alder 18 til 65 · Alle køn · Opdateret 19. dec. 2024 · NCT05184335

Skizofreni forsøg i andre byer

Andre studier i Chicago

Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.